Rex L.

Rex L. has extensive work experience in the field of clinical pharmacology. Rex currently holds the position of Vice President of Clinical Pharmacology at SpringWorks Therapeutics, where they have been working since June 2023. Prior to this, they held the role of Director of Clinical Pharmacology at the same company from July 2022 to June 2023, and Associate Director of Clinical Pharmacology from July 2020 to July 2022.

Before joining SpringWorks Therapeutics, Rex worked at Bausch Health Companies Inc. as a Senior Manager of Nonclinical and Clinical Pharmacology from January 2020 to July 2020.

Rex also has significant experience with Nuventra Pharma Sciences, where they held various positions over a span of several years. Rex served as a Scientist III of Clinical Pharmacology from April 2019 to January 2020, Associate Director of Program Management from May 2017 to January 2020, Manager of Clinical Pharmacology from May 2017 to April 2019, Associate Director of Project Management from January 2016 to April 2017, Clinical Pharmacology Associate from May 2014 to April 2017, Manager of Business Operations from September 2015 to December 2015, and Project Management Specialist from May 2014 to December 2015.

Furthermore, Rex has prior research experience at the University of North Carolina at Chapel Hill, where they served as a Predoctoral Research Associate from August 2007 to February 2014. Rex also worked as a Research Associate and the Director of the ES Mutagenesis Facility from August 2005 to July 2007 at the same institution.

Before their time at the University of North Carolina, Rex worked as a Teaching Assistant for a course on Molecular Embryology of the Mouse at Cold Spring Harbor Laboratory in June 2009. Rex also gained experience as a Research Technician at the Human Genome Sequencing Center at Baylor College of Medicine from May 2004 to July 2005.

Overall, Rex L. has a wide range of experience in clinical pharmacology, research, project management, and business operations.

Rex L. obtained a Ph.D. in Genetics & Molecular Biology from the University of North Carolina at Chapel Hill School of Medicine, where they studied from 2007 to 2014. Prior to that, they earned a Bachelor of Science degree in Biochemistry from Texas A&M University, attending from 1999 to 2004.